Sustained release tablets containing cefaclor active component and preparation method thereof

Sustained release tablets containing cefaclor active component and preparation method thereof

The invention discloses a sustained-release preparation containing the active ingredient of cefaclor, which consists of the cefaclor, acrylics II, slow release stroma of hydroxypropyl methylcellulose, cementing agent, loading agent and other supplementary materials; wherein, the proportion by weight...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PANG DONGYING, YANG FUZHEN
Format: Patent
Sprache:chi ; eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator PANG DONGYING
YANG FUZHEN
description The invention discloses a sustained-release preparation containing the active ingredient of cefaclor, which consists of the cefaclor, acrylics II, slow release stroma of hydroxypropyl methylcellulose, cementing agent, loading agent and other supplementary materials; wherein, the proportion by weight among the cefaclor, the slow release stroma and the acrylics II is 1:0.1-1:0.01-0.1. After being taken, the cefaclor sustained-release tablets can be slowly and continuously released according to the requirements to maintain effective blood level, thus achieving the action of controlled release. The sustained-release preparation has the characteristics of lasting action, low toxic and side effect, few times for taking medicine, and utilizing the minimum dose to achieve the best healing efficacy; furthermore, blood concentration is stable, the incidence rate of untoward effect is reduced, and the sustained-release preparation is more applicable to the use of the patients.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN101352442BB</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN101352442BB</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN101352442BB3</originalsourceid><addsrcrecordid>eNqNyjEKwkAQRuE0FqLeYbAXTKIXSFCsbLSVMG7-mIXNzLI7en4VPIDVK743L26XZzb2gp4SAjiDjO8BlsmpfMXLgxwGdkETsTP_woemqAIxYukpJkRObF6FJtioPdmIBB2WxWzgkLH6dVGsj4dre9ogaocc2UFgXXsut2W9r3a7qmnqv6Y33Og9dg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Sustained release tablets containing cefaclor active component and preparation method thereof</title><source>esp@cenet</source><creator>PANG DONGYING ; YANG FUZHEN</creator><creatorcontrib>PANG DONGYING ; YANG FUZHEN</creatorcontrib><description>The invention discloses a sustained-release preparation containing the active ingredient of cefaclor, which consists of the cefaclor, acrylics II, slow release stroma of hydroxypropyl methylcellulose, cementing agent, loading agent and other supplementary materials; wherein, the proportion by weight among the cefaclor, the slow release stroma and the acrylics II is 1:0.1-1:0.01-0.1. After being taken, the cefaclor sustained-release tablets can be slowly and continuously released according to the requirements to maintain effective blood level, thus achieving the action of controlled release. The sustained-release preparation has the characteristics of lasting action, low toxic and side effect, few times for taking medicine, and utilizing the minimum dose to achieve the best healing efficacy; furthermore, blood concentration is stable, the incidence rate of untoward effect is reduced, and the sustained-release preparation is more applicable to the use of the patients.</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20101208&amp;DB=EPODOC&amp;CC=CN&amp;NR=101352442B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76418</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20101208&amp;DB=EPODOC&amp;CC=CN&amp;NR=101352442B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PANG DONGYING</creatorcontrib><creatorcontrib>YANG FUZHEN</creatorcontrib><title>Sustained release tablets containing cefaclor active component and preparation method thereof</title><description>The invention discloses a sustained-release preparation containing the active ingredient of cefaclor, which consists of the cefaclor, acrylics II, slow release stroma of hydroxypropyl methylcellulose, cementing agent, loading agent and other supplementary materials; wherein, the proportion by weight among the cefaclor, the slow release stroma and the acrylics II is 1:0.1-1:0.01-0.1. After being taken, the cefaclor sustained-release tablets can be slowly and continuously released according to the requirements to maintain effective blood level, thus achieving the action of controlled release. The sustained-release preparation has the characteristics of lasting action, low toxic and side effect, few times for taking medicine, and utilizing the minimum dose to achieve the best healing efficacy; furthermore, blood concentration is stable, the incidence rate of untoward effect is reduced, and the sustained-release preparation is more applicable to the use of the patients.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyjEKwkAQRuE0FqLeYbAXTKIXSFCsbLSVMG7-mIXNzLI7en4VPIDVK743L26XZzb2gp4SAjiDjO8BlsmpfMXLgxwGdkETsTP_woemqAIxYukpJkRObF6FJtioPdmIBB2WxWzgkLH6dVGsj4dre9ogaocc2UFgXXsut2W9r3a7qmnqv6Y33Og9dg</recordid><startdate>20101208</startdate><enddate>20101208</enddate><creator>PANG DONGYING</creator><creator>YANG FUZHEN</creator><scope>EVB</scope></search><sort><creationdate>20101208</creationdate><title>Sustained release tablets containing cefaclor active component and preparation method thereof</title><author>PANG DONGYING ; YANG FUZHEN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN101352442BB3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2010</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>PANG DONGYING</creatorcontrib><creatorcontrib>YANG FUZHEN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PANG DONGYING</au><au>YANG FUZHEN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Sustained release tablets containing cefaclor active component and preparation method thereof</title><date>2010-12-08</date><risdate>2010</risdate><abstract>The invention discloses a sustained-release preparation containing the active ingredient of cefaclor, which consists of the cefaclor, acrylics II, slow release stroma of hydroxypropyl methylcellulose, cementing agent, loading agent and other supplementary materials; wherein, the proportion by weight among the cefaclor, the slow release stroma and the acrylics II is 1:0.1-1:0.01-0.1. After being taken, the cefaclor sustained-release tablets can be slowly and continuously released according to the requirements to maintain effective blood level, thus achieving the action of controlled release. The sustained-release preparation has the characteristics of lasting action, low toxic and side effect, few times for taking medicine, and utilizing the minimum dose to achieve the best healing efficacy; furthermore, blood concentration is stable, the incidence rate of untoward effect is reduced, and the sustained-release preparation is more applicable to the use of the patients.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN101352442BB
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Sustained release tablets containing cefaclor active component and preparation method thereof
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T13%3A06%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PANG%20DONGYING&rft.date=2010-12-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN101352442BB%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true